0002004379-24-000001.txt : 20241001 0002004379-24-000001.hdr.sgml : 20241001 20241001171208 ACCESSION NUMBER: 0002004379-24-000001 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20241001 DATE AS OF CHANGE: 20241001 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NewAmsterdam Pharma Co N.V. CENTRAL INDEX KEY: 0001936258 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-41562 FILM NUMBER: 241344317 BUSINESS ADDRESS: STREET 1: GOOIMEER 2-35 CITY: NARRDEN STATE: P7 ZIP: 1411 DC BUSINESS PHONE: 35 206 2971 MAIL ADDRESS: STREET 1: GOOIMEER 2-35 CITY: NARRDEN STATE: P7 ZIP: 1411 DC FORMER COMPANY: FORMER CONFORMED NAME: NewAmsterdam Pharma Co B.V. DATE OF NAME CHANGE: 20220701 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Kooij Louise Frederika CENTRAL INDEX KEY: 0002004379 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O NEWAMSTERDAM PHARMA COMPANY N.V. STREET 2: GOOIMEER 2-35 CITY: NAARDEN STATE: P7 ZIP: 1411 DC 144 1 primary_doc.xml 144 0002004379 XXXXXXXX LIVE 0001936258 NewAmsterdam Pharma Co N.V. 001-41562 GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971 Kooij Louise Frederika Officer Ordinary shares, nominal value EUR 0.12 per share Cooperatieve Rabobank U.A.

Croeselaan 18 Utrecht P7 3521CB

45000 778050.00 90015357 10/01/2024 Nasdaq Global Market Ordinary shares, nominal value EUR 0.12 per share 09/30/2024 Option Exercise NewAmsterdam Pharma Company N.V. N 45000 09/27/2024 Cash Y 10/01/2024 /s/ Louise Kooij